Squadron Capital Management LLC - Significant Ownership

Signature - Title
/s/ Matthew Sesterhenn - Partner
Location
Hinsdale, IL
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Squadron Capital Management LLC.

Notify me when Squadron Capital Management LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Squadron Capital Management LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RLMD RELMADA THERAPEUTICS, INC. Common Stock ($.001 par value) 9.9% $2.57M $974K 3.3M +60.9% Squadron Capital Management LLC Jun 30, 2025
KTTA Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share 9.9% $1.58M 2.25M Squadron Capital Management LLC Nov 28, 2025
PALI PALISADE BIO, INC. Common Stock, par value $0.01 per share 8.5% $4.79M 8.25M Squadron Capital Management LLC Oct 1, 2025
TRAW Traws Pharma, Inc. Common Stock, par value $.01 per share 8.4% $1.12M $322K 591K +40.5% Squadron Capital Management LLC Sep 30, 2025
SPRBD SPRUCE BIOSCIENCES, INC. Common Stock, par value $0.0001 per share 6.6% $641K 70K Squadron Capital Management LLC Oct 8, 2025
NXTC NextCure, Inc. Common Stock, $0.001 par value per share 6.5% $1.02M 174K Squadron Capital Management LLC Oct 21, 2025

Schedules 13D/G Reported by Squadron Capital Management LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.